Get the Daily Brief
Latest Biotech News
Saga Diagnostics Scores Medicare Coverage for Breast Cancer MRD Test
Saga Diagnostics achieved a key milestone with Medicare coverage granted for its Pathlight molecular residual disease test, designed to monitor breast cancer recurrence across all subtypes. Backed...
Myriad Genetics Secures $200M Credit Facility from OrbiMed
Myriad Genetics closed a $200 million credit deal with OrbiMed to support its growth and operational objectives. The credit includes $125 million funded with an option for an additional $75...
Prima Mente Launches Alzheimer’s Epigenetic Clinical Study
Prima Mente is set to initiate a clinical trial deploying its Pleiades whole-epigenome platform to stratify Alzheimer’s patients for optimized management. Utilizing machine learning-enabled...
Respiratory Viral Infections Trigger Reactivation of Dormant Breast Cancer Cells
A pivotal study in Nature reveals that common respiratory viruses such as SARS-CoV-2 and influenza can awaken dormant metastatic breast cancer cells in the lung microenvironment. Experiments in...
Moderna Cuts Workforce by 10% Amid Cost Reduction Drive
Moderna announced layoffs affecting more than 500 employees, approximately 10% of its workforce, as part of a $1.5 billion cost-saving initiative through 2027. CEO Stéphane Bancel emphasized the...
Frazier Life Sciences Raises $1.3 Billion for Early-Stage Biotech
Venture firm Frazier Life Sciences closed an oversubscribed $1.3 billion fund targeting early-stage biopharmaceutical investments, surpassing the previous $987 million raised in 2022. This fund...
Eli Lilly’s Mounjaro Shows Cardiovascular Benefits in Large Trial
Eli Lilly’s diabetes medication Mounjaro demonstrated cardiovascular outcomes comparable to existing treatments in a large-scale trial. The drug reduced the risk of heart-related events by 8%...
FDA Leadership Shift and Sarepta Gene Therapy Controversy
Vinay Prasad's abrupt departure as Director of the FDA’s Center for Biologics Evaluation and Research (CBER) has sent shockwaves through the biotech sector. Prasad's tenure, though brief, was...
Novo Nordisk Faces Market Challenges and Leadership Change
Novo Nordisk revised its sales growth forecast downward for 2025 due to continued competition from compounded GLP-1 drugs and market challenges affecting its obesity medications, Wegovy and...
AI Advances in Biotechnology Research and Clinical Applications
Artificial intelligence continues to transform biotechnology, with new developments in automated gene editing and clinical trial recruitment. The CRISPR-GPT system integrates large language models...
Breakthroughs in Cancer Immunotherapy and Tumor Biology
Recent studies have revealed novel mechanisms and therapeutic targets underpinning cancer progression and treatment response. Advances include the development of a machine learning model...
Microbiome and Metabolic Disease Therapeutic Insights
Researchers have uncovered critical relationships between gut microbiota-derived proteins and metabolic regulation, opening avenues for chronic disease therapies. Identification of bacterial...
Regulatory Approvals Boost Rare Disease and Oncology Treatment Options
The FDA has granted approvals expanding treatment options for rare diseases and cancers. Saga Diagnostics secured Medicare coverage for its Pathlight MRD test monitoring breast cancer recurrence...
Climate and Environmental Health Impacts in Biotech and Public Health
New insights highlight the intersection of climate change, environmental factors, and health outcomes. Studies reveal a rapid decline of freshwater resources worldwide and increased heat-related...
Gene Therapy Innovations for Pediatric and Infectious Diseases
Groundbreaking gene therapy approaches promise durable protection and treatment for pediatric and infectious diseases. A single injection of adeno-associated virus-vectored broadly neutralizing...
Precision Diagnostics and Multi-Omics in Disease Management
Technological advances in diagnostics leverage multi-omics and AI to improve disease detection and personalized medicine. Novel urinary vesicle proteomics identify CD35 as a biomarker for early...
FDA Leadership Shakeup - Vinay Prasad Exits Biologics Center Amid Sarepta Controversy
Vinay Prasad, head of the FDA’s Center for Biologics Evaluation and Research (CBER), resigned unexpectedly after a tumultuous three-month tenure marked by controversial regulatory actions...
Madrigal Pharmaceuticals’ $2B Deal for Preclinical GLP-1 Therapy Boosts MASH Pipeline
Madrigal Pharmaceuticals struck a $2 billion global licensing agreement with CSPC Pharmaceutical Group for SYH-2086, a preclinical oral glucagon-like peptide-1 (GLP-1) receptor agonist. The deal...
GeneDx Reports Robust Genomic Testing Growth and Raised 2025 Revenue Forecast
Genetic diagnostics firm GeneDx reported a strong Q2 2025 with 49% revenue growth year-over-year driven by whole-exome and whole-genome testing. The company achieved $102.7 million in quarterly...
AI-Driven Advances: CRISPR-GPT and Virtual Labs Automate Gene Editing and Scientific Research
Researchers from leading institutions have developed AI platforms that leverage large language models to automate complex gene-editing experiment design and interdisciplinary scientific research....